BlackRock, Inc. 13D and 13G filings for NeoGenomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-17 5:45 pm Sale | 2025-09-30 | 13G | NEOGENOMICS INC NEO | BlackRock Inc. BLK | 18,861,974 14.600% | -1,119,019 (-5.60%) | Filing |
| 2024-01-22 3:52 pm Sale | 2023-12-31 | 13G | NEOGENOMICS INC NEO | BlackRock Inc. BLK | 19,980,993 15.700% | -1,951,630 (-8.90%) | Filing |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | NEOGENOMICS INC NEO | BlackRock Inc. BLK | 21,932,623 17.400% | 2,604,369 (+13.47%) | Filing |
| 2022-01-27 1:59 pm Unchanged | 2021-12-31 | 13G | NEOGENOMICS INC NEO | BlackRock Inc. BLK | 19,328,254 15.700% | 0 (Unchanged) | Filing |
| 2022-01-25 6:45 pm Purchase | 2021-12-31 | 13G | NEOGENOMICS INC NEO | BlackRock Inc. BLK | 19,328,254 15.700% | 2,081,684 (+12.07%) | Filing |